Vicarious Surgical (RBOT) Total Non-Current Liabilities (2020 - 2025)

Vicarious Surgical's (RBOT) quarterly Total Non-Current Liabilities came in at $14.7 million in Q3 2025, down 31.56% year-on-year from $21.5 million in Q3 2024, and down 13.43% on a QoQ basis from $17.0 million in Q2 2025.

Vicarious Surgical (RBOT) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has 6 years of Total Non-Current Liabilities data on file, last reported at $14.7 million in Q3 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 31.56% year-over-year to $14.7 million in Q3 2025; TTM through Sep 2025 was $14.7 million, a 31.56% decrease from a year earlier, with the FY2024 full-year figure at $20.2 million, down 3.94% from the prior year.
  • Total Non-Current Liabilities for Q3 2025 stood at $14.7 million, down from $17.0 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for RBOT reached as high as $27.0 million in Q3 2022 and fell as low as $5.4 million in Q3 2021.
  • Historically, Total Non-Current Liabilities has averaged $18.7 million across 5 years, with a median of $20.4 million in 2024.
  • Across the five-year window, Total Non-Current Liabilities jumped 396.12% in 2022 and tumbled 31.56% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $8.6 million in 2021, then jumped by 171.1% to $23.2 million in 2022, then retreated by 9.3% to $21.1 million in 2023, then fell by 3.94% to $20.2 million in 2024, then retreated by 27.32% to $14.7 million in 2025.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $14.7 million in Q3 2025, $17.0 million in Q2 2025, and $20.1 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Vicarious Surgical 654,984.55 -9.14 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 14.71 Mn
Jun 30, 2025 16.99 Mn
Mar 31, 2025 20.10 Mn
Dec 31, 2024 20.23 Mn
Sep 30, 2024 21.49 Mn
Jun 30, 2024 20.38 Mn
Mar 31, 2024 18.58 Mn
Dec 31, 2023 21.07 Mn
Sep 30, 2023 21.86 Mn
Jun 30, 2023 21.82 Mn
Mar 31, 2023 21.26 Mn
Dec 31, 2022 23.23 Mn
Sep 30, 2022 26.99 Mn
Jun 30, 2022 22.58 Mn
Mar 31, 2022 22.45 Mn
Dec 31, 2021 8.57 Mn
Sep 30, 2021 5.44 Mn
Jun 30, 2021 14.24 Mn
Mar 31, 2021 13.59 Mn
Dec 31, 2020 -28.48 Mn